Glooko, which offers a unified platform for diabetes management, is teaming-up with DreaMed Diabetes to commercialize DreaMed’s Advisor algorithm using the Glooko platform.

The two companies aim to improve insulin management for over 30 million people with type 1 diabetes globally, about 35% of whom currently use insulin pumps. Glooko’s diabetes platform enables diabetics to download and visualize data from their diabetes device using their smartphone, while also making the data available to clinicians via a cloud service.

The collaboration with DreaMed Diabetes is part of Glooko’s idea to create an app store for diabetes algorithms and tools.With the addition of DreaMed’s MD-Logic Pump Advisor, insulin pump data can be assessed for patterns that yield personalized recommendations for such pump-related settings as basal rates and insulin-to-carb ratios. These recommendations are made available to clinicians via Glooko’s Population Management application from where they can review the therapeutic basis behind the recommended adjustment. Once approved, these recommendations are made available via the Glooko app on the user’s mobile phone.

For Glooko, the collaboration with DreaMed Diabetes is part of the idea to create an “app store for diabetes algorithms and tools”, all of which leverage Glooko’s diabetes data engine and mobile app/web capabilities.

“Enabling partners to use Glooko’s vast diabetes dataset to deliver personalized insights at the patient-level will give clinicians the information they need to provide impactful recommendations that can improve health outcomes,” Rick Altinger, Glooko CEO, said in a statement.

DreaMed on its end wants to transform its Advisor into a necessary analytical component in any diabetes management system offering advanced personalized medicine. Future collaborations will include partnering with stakeholders that generate, collect and store patient data, to provide real-time glucose balance and behavioral guidance. Such collaborations can transform collected data into actionable information, to enable DreaMed partners to provide more holistic and simple solutions for diabetes patients.

Earlier this year, Glooko has teamed-up with Insulet to launch the Insulet Provided Glooko system. Before that, the company launched the Glooko Office Kiosk for in-clinic diabetes care.